This section provides various financial ratios derived from the company's financial statements to help assess its performance and financial health. Below are Return on Equity, Debt to Asset Ratio, Cash Ratio, Current Ratio for RNTX as of 2025-09-30.
| Financial Ratios | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
| Current Ratio | 90.077 | 85.807 | - |
| Cash Ratio | 70.474 | 74.37 | - |
| Debt to Asset Ratio | 13.995 | 16.469 | - |
| Return on Equity | -12.083 | -14.234 | - |
Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics, Inc. (RNTX)